October 17, 2024- The CDC issued a health advisory Oct. 12 with guidelines on how systems and leaders can manage the supply disruptions of peritoneal dialysis and intravenous solutions, according to Becker’s Hospital Review. Baxter said it anticipates supply allocations will rise back up to 90% to 100% levels by the end of the year, according to an Oct. 9 company press release. Until then, recommendations for healthcare providers from the CDC for addressing the IV shortage include assessing inventory, supply, and conserving available IV solutions, reporting any potential shortages or interruptions to the FDA, communicating changes in practice, disruption, new shortages and action plans to hospital leadership, frontline staff and patients, and more.
Read more here from Becker’s Hospital Review.